DK1320542T3 - Gruppe B streptokokpolypeptider-nukleinsyrer og terapeutiske sammensætninger og vacciner deraf - Google Patents

Gruppe B streptokokpolypeptider-nukleinsyrer og terapeutiske sammensætninger og vacciner deraf

Info

Publication number
DK1320542T3
DK1320542T3 DK01959633T DK01959633T DK1320542T3 DK 1320542 T3 DK1320542 T3 DK 1320542T3 DK 01959633 T DK01959633 T DK 01959633T DK 01959633 T DK01959633 T DK 01959633T DK 1320542 T3 DK1320542 T3 DK 1320542T3
Authority
DK
Denmark
Prior art keywords
polypeptides
nucleic acids
ema
streptococcal
group
Prior art date
Application number
DK01959633T
Other languages
Danish (da)
English (en)
Inventor
Elisabeth Adderson
John Bohnsack
Original Assignee
St Jude Childrens Res Hospital
Univ Utah Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Jude Childrens Res Hospital, Univ Utah Res Found filed Critical St Jude Childrens Res Hospital
Application granted granted Critical
Publication of DK1320542T3 publication Critical patent/DK1320542T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK01959633T 2000-08-08 2001-08-08 Gruppe B streptokokpolypeptider-nukleinsyrer og terapeutiske sammensætninger og vacciner deraf DK1320542T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63434100A 2000-08-08 2000-08-08
PCT/US2001/024795 WO2002012294A2 (fr) 2000-08-08 2001-08-08 Acides nucleiques de streptocoque de groupe b, polypeptides, compositions therapeutiques et vaccins correspondants

Publications (1)

Publication Number Publication Date
DK1320542T3 true DK1320542T3 (da) 2007-09-10

Family

ID=24543390

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01959633T DK1320542T3 (da) 2000-08-08 2001-08-08 Gruppe B streptokokpolypeptider-nukleinsyrer og terapeutiske sammensætninger og vacciner deraf

Country Status (11)

Country Link
US (2) US7128919B2 (fr)
EP (2) EP1320542B9 (fr)
AT (1) ATE360640T1 (fr)
AU (1) AU2001281168A1 (fr)
CA (1) CA2417357A1 (fr)
CY (1) CY1107702T1 (fr)
DE (1) DE60128115T2 (fr)
DK (1) DK1320542T3 (fr)
ES (1) ES2286133T3 (fr)
PT (1) PT1320542E (fr)
WO (1) WO2002012294A2 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2189473A3 (fr) 2000-10-27 2010-08-11 Novartis Vaccines and Diagnostics S.r.l. Acides nucléiques et protéines dérivés des groupes de streptocoques A et B
GB0107661D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
US20070053924A1 (en) * 2002-08-26 2007-03-08 Herve Tettelin Conserved and specific streptococcal genomes
ES2505695T3 (es) 2003-07-31 2014-10-10 Novartis Vaccines And Diagnostics, Inc. Composiciones inmunógenas para Streptococcus pyogenes
US20070110763A1 (en) * 2003-08-15 2007-05-17 Stephane Rioux Polypeptides of streptococcus pyogenes
US8945589B2 (en) * 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
EP2612679A1 (fr) 2004-07-29 2013-07-10 Novartis Vaccines and Diagnostics, Inc. Compositions immunogènes pour une bactérie à gram positif telle que streptococcus agalactiae
WO2006018319A1 (fr) * 2004-08-18 2006-02-23 Bayer Cropscience Gmbh Vegetaux a activite plastidique accrue de l'enzyme r3 de phosphorylation de l'amidon
JP2008544949A (ja) * 2004-10-08 2008-12-11 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 化膿性レンサ球菌のための免疫激性組成物および治療用組成物
WO2006050341A2 (fr) 2004-11-01 2006-05-11 The Brigham And Women's Hospital, Inc. Polysaccharides streptococciques modifies et leurs utilisations
GB0502095D0 (en) * 2005-02-01 2005-03-09 Chiron Srl Conjugation of streptococcal capsular saccharides
PT2054431E (pt) * 2006-06-09 2011-11-03 Novartis Ag Confórmeros de adesinas bacterianas
WO2008108830A2 (fr) * 2006-10-30 2008-09-12 Novartis Ag Compositions immunogènes et thérapeutiques pour streptococcus pyogenes
MX2010002773A (es) 2007-09-12 2010-03-31 Novartis Ag Antigenos mutantes de gas57 y anticuerpos de gas57.
JP5656642B2 (ja) 2007-12-21 2015-01-21 ノバルティス アーゲー ストレプトリシンｏの変異体形態
AU2010203698B2 (en) 2009-01-06 2016-07-21 C3 Jian, Inc. Targeted antimicrobial moieties
CN102481349B (zh) * 2009-01-12 2014-10-15 诺华股份有限公司 抗革兰氏阳性细菌疫苗中的Cna_B结构域
AR084158A1 (es) * 2010-12-10 2013-04-24 Merck Sharp & Dohme Formulaciones que mitigan la agregacion inducida por agitacion de composiciones inmunogenicas
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US20220211859A1 (en) 2019-05-10 2022-07-07 Glaxosmithkline Biologicals Sa Conjugate production
CN115287244B (zh) * 2022-06-28 2023-07-25 北部湾大学 鱼源无乳链球菌internalin基因LRR结构域敲除突变株及其制备方法和应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3654090A (en) 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
USRE31006E (en) 1968-09-24 1982-08-03 Akzona Incorporated Process for the demonstration and determination of reaction components having specific binding affinity for each other
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4342566A (en) 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
US4356263A (en) 1980-06-09 1982-10-26 President And Fellows Of Harvard College Method of making a polysaccharide vaccine
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4631211A (en) 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
US5302386A (en) 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US5010175A (en) 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
CA2006596C (fr) 1988-12-22 2000-09-05 Rika Ishikawa G-csf modifie chimiquement
US5354844A (en) 1989-03-16 1994-10-11 Boehringer Ingelheim International Gmbh Protein-polycation conjugates
US5648241A (en) 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
US5139749A (en) 1990-06-22 1992-08-18 Tas, Inc. Fluidized calcining process
EP0573608A1 (fr) 1991-02-07 1993-12-15 Molecumetics, Ltd. Produits mimetiques de conformation restreinte de tours beta et bombements beta, et peptides les contenant
CA2082951C (fr) 1991-03-15 1999-12-21 Robert M. Platz Administration au niveau pulmonaire du facteur stimulant la proliferation des granulocytes
PT667787E (pt) 1992-09-24 2001-10-31 Brigham & Womens Hospital Vacinas de conjugado de polissacarido-proteina de estreptococos do grupo b do tipo ii e tipo v
ZA937034B (en) 1992-09-24 1995-06-23 Brigham & Womens Hospital Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
ES2204921T3 (es) 1993-05-27 2004-05-01 Selectide Corporation Bibliotecas de fase solida codificadas, segregadas topologicamente.
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
AU2192497A (en) * 1996-02-29 1998-09-18 Washington University Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof
CN1268178A (zh) 1997-05-06 2000-09-27 人体基因组科学有限公司 粪肠球菌多核苷酸和多肽
EP2053126A1 (fr) 1998-07-27 2009-04-29 Sanofi Pasteur Limited Protéines de pneumonie à streptocoques et molécules d'acide nucléique
WO2000006736A2 (fr) 1998-07-27 2000-02-10 Microbial Technics Limited Acides nucleiques et proteines de streptococcus groupe b
EP1121149A4 (fr) * 1998-08-31 2002-03-20 Inhibitex Inc Procede d'immunotherapie contre les infections staphylococciques comprenant la selection des donneurs et la stimulation des donneurs
EP1233780A4 (fr) 1999-04-15 2004-09-22 Univ California Identification du gene sortase
AU5755500A (en) 1999-06-21 2001-01-09 University Of Utah Research Foundation Isolated genes from virulent group B streptococcus agalactiae
US9002545B2 (en) 2011-01-07 2015-04-07 Wabtec Holding Corp. Data improvement system and method

Also Published As

Publication number Publication date
EP1320542B1 (fr) 2007-04-25
DE60128115D1 (de) 2007-06-06
PT1320542E (pt) 2007-08-06
DE60128115T2 (de) 2008-03-06
EP1320542B9 (fr) 2007-09-12
EP1810978A3 (fr) 2007-10-24
ATE360640T1 (de) 2007-05-15
US7645577B2 (en) 2010-01-12
CA2417357A1 (fr) 2002-02-14
AU2001281168A1 (en) 2002-02-18
US7128919B2 (en) 2006-10-31
WO2002012294A2 (fr) 2002-02-14
EP1810978B1 (fr) 2013-02-13
CY1107702T1 (el) 2013-04-18
ES2286133T3 (es) 2007-12-01
EP1810978A2 (fr) 2007-07-25
US20070178116A1 (en) 2007-08-02
EP1320542A2 (fr) 2003-06-25
WO2002012294A3 (fr) 2003-04-10
US20040071729A1 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
DK1320542T3 (da) Gruppe B streptokokpolypeptider-nukleinsyrer og terapeutiske sammensætninger og vacciner deraf
IL264925A (en) Isolated or recombinant proteins that induce an immune response against S. PYOGENES, preparations containing them and their uses
CA2356836A1 (fr) Nouveaux antigenes de streptococcus
EP3167900B1 (fr) Vaccin contre des streptocoques
WO2002083855A3 (fr) Nouveaux cadres de lecture ouverts de streptococcus pneumoniae codant pour des antigenes polypeptidiques, et leurs utilisations
AR003124A1 (es) Proteinas estreptococicas de shock termico miembros de la familia de hsp7270,secuencia de adn que codifica para dichos polipeptidos, vector deexpresion, molecula de adn recombinante, metodo para producir un polipeptido o fragmento del mismo, anticuerpo o fragmento del mismo y anticuerpo monoclonal,
NZ551802A (en) A hyperimmune serum-reactive antigen consisting of a polypeptide comprising an amino acid sequence in SEQ ID NO:422 and antigenic fragments thereof
HUP0500459A2 (hu) Streptococcus suis vakcinák és diagnosztikai tesztek
NO20070618L (no) Forbindelser og fremgangsmater for immunterapi og diagnose av tuberkulose.
AU6576800A (en) Use of a polypeptide for detecting, preventing or treating pathological condition associated with a degenerative, neurological or autoimmune disease
KR20070101197A (ko) 유전자와 단백질들, 및 그들의 사용
JP2009542196A (ja) 小型の化膿連鎖球菌抗原およびそれらの使用
WO2002050277A3 (fr) Proteines et acides nucleiques codant pour celles-ci
PT1219711E (pt) Vacina de lawsonia intracellularis
HUP0100267A2 (hu) Helicobacter pylori eredetű nukleinsav- és aminosav-szekvenciák és a megfelelő nukleinsavakat vagy peptideket tartalmazó vakcina-készítmények
WO2004020609A3 (fr) Antigenes streptococcus pneumoniae pour le diagnostic, le traitement et la prevention d'infections evolutives
BR9908476A (pt) Peptìdeo, composição terapêutica, e, processo para conferir imunidade protetora a um paciente, contra a infecção de s. pneumoniae
CA2718473A1 (fr) Peptides luttant contre s. pneumoniae et compositions, methodes et utilisations associees
Chessa et al. Genetic immunization with the immunodominant antigen P48 of Mycoplasma agalactiae stimulates a mixed adaptive immune response in BALBc mice
ATE366583T1 (de) Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407
KR20080052693A (ko) 유전자, 단백질 및 그들의 용도
EP2450053A1 (fr) Nouvel antigène de pathogènes entérocoques et leur utilisation en tant que composant de vaccin pour le traitement et/ou la prévention
DK1939217T3 (da) Plasmider kodende for p185neu-proteinsekvensvarianter og terapeutiske anvendelser deraf
WO2002050276A3 (fr) Nouvelle proteine et acides nucleiques codant pour celle-ci
HUP0200832A2 (hu) Babesia canis oltóanyag